Today's edition of The Motley Fool's health-care show Market Checkup covers a new drug application from pharmaceutical giant AstraZeneca and a biotech company rumored to be for sale.
David Williamson owns shares of Pfizer and Amarin. Alison Southwick and Max Macaluso, Ph.D., have no position in any stocks mentioned. The Motley Fool recommends BioMarin Pharmaceutical. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.